China National Medicines Corp Ltd Free Cash Flow Generation Index
China National Medicines Corp Ltd free cash flow generation index. China National Medicines Corp Ltd (600511) has a Free Cash Flow Generation Index of 0.97x as of June 2025. Free cash flow of CN¥369.51 Million represents 1% of operating cash flow (CN¥382.74 Million). Check China National Medicines Corp Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of China National Medicines Corp Ltd (2002–2024)
Free cash flow generation index of China National Medicines Corp Ltd from 2002 to 2024. Historical FCF Generation Index trend for China National Medicines Corp Ltd across 22 annual periods. Explore 600511 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
China National Medicines Corp Ltd Free Cash Flow Generation Index by Year (2002–2024)
China National Medicines Corp Ltd free cash flow generation index by year from 2002 to 2024. Year-by-year Free Cash Flow Generation Index for China National Medicines Corp Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of China National Medicines Corp Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.92x | CN¥1.53 Billion | CN¥1.66 Billion | CN¥130.77 Million | ▼ -2.7% |
| 2023 | 0.95x | CN¥2.58 Billion | CN¥2.73 Billion | CN¥145.12 Million | ▲ +0.1% |
| 2022 | 0.95x | CN¥2.27 Billion | CN¥2.40 Billion | CN¥129.78 Million | ▼ -0.6% |
| 2021 | 0.95x | CN¥1.86 Billion | CN¥1.96 Billion | CN¥95.07 Million | ▲ +0.5% |
| 2020 | 0.95x | CN¥1.23 Billion | CN¥1.30 Billion | CN¥69.05 Million | ▼ -0.5% |
| 2019 | 0.95x | CN¥1.69 Billion | CN¥1.78 Billion | CN¥85.72 Million | ▲ +10.0% |
| 2018 | 0.87x | CN¥849.19 Million | CN¥981.65 Million | CN¥132.46 Million | ▼ -7.2% |
| 2017 | 0.93x | CN¥1.00 Billion | CN¥1.07 Billion | CN¥73.25 Million | ▼ -0.1% |
| 2016 | 0.93x | CN¥551.38 Million | CN¥591.25 Million | CN¥39.88 Million | ▲ +10.4% |
| 2015 | 0.84x | CN¥371.82 Million | CN¥440.29 Million | CN¥68.47 Million | ▲ +161.5% |
| 2014 | 0.32x | CN¥70.72 Million | CN¥218.94 Million | CN¥148.22 Million | ▼ -6.2% |
| 2013 | 0.34x | CN¥63.91 Million | CN¥185.56 Million | CN¥121.66 Million | ▲ +294.7% |
| 2012 | 0.09x | CN¥16.22 Million | CN¥185.87 Million | CN¥169.65 Million | ▼ -90.6% |
| 2010 | 0.92x | CN¥294.12 Million | CN¥318.21 Million | CN¥24.09 Million | ▲ +1.3% |
| 2009 | 0.91x | CN¥232.85 Million | CN¥255.18 Million | CN¥22.33 Million | ▼ -1.4% |
| 2008 | 0.93x | CN¥200.89 Million | CN¥217.10 Million | CN¥16.21 Million | ▲ +3.8% |
| 2007 | 0.89x | CN¥70.86 Million | CN¥79.48 Million | CN¥8.61 Million | ▲ +10.9% |
| 2006 | 0.80x | CN¥97.69 Million | CN¥121.50 Million | CN¥23.81 Million | ▲ +45.5% |
| 2005 | 0.55x | CN¥50.96 Million | CN¥92.20 Million | CN¥41.24 Million | ▲ +171.7% |
| 2004 | -0.77x | CN¥-37.90 Million | CN¥49.18 Million | CN¥87.08 Million | ▲ +99.6% |
| 2003 | -171.79x | CN¥-90.39 Million | CN¥526.15K | CN¥90.92 Million | ▼ -260133.2% |
| 2002 | 0.07x | CN¥1.00 Million | CN¥15.19 Million | CN¥14.19 Million | — |